Genetic basis of polycystic ovary syndrome (PCOS): current perspectives

MJ Khan, A Ullah, S Basit - The application of clinical genetics, 2019 - Taylor & Francis
Polycystic ovary syndrome (PCOS) is a common infertility disorder affecting a significant
proportion of the global population. It is the main cause of anovulatory infertility in women …

Treatment strategies for women with polycystic ovary syndrome

P Jin, Y Xie - Gynecological Endocrinology, 2018 - Taylor & Francis
Polycystic ovary syndrome (PCOS) is a common endocrine disorder in women, and it is the
main cause of infertility in women of reproductive age due to anovulation. PCOS also …

Pathophysiology and types of dyslipidemia in PCOS

E Diamanti-Kandarakis, AG Papavassiliou… - Trends in Endocrinology …, 2007 - cell.com
Polycystic ovary syndrome (PCOS) is an endocrinopathy that affects women of reproductive
age. PCOS shares components with the metabolic syndrome and has broad health …

Polycystic ovarian syndrome: pathophysiology, molecular aspects and clinical implications

E Diamanti-Kandarakis - Expert Reviews in molecular medicine, 2008 - cambridge.org
Polycystic ovarian syndrome (PCOS) is universally recognised as the commonest
endocrinopathy of women. The definition and the aetiological hypotheses of PCOS are …

Polycystic ovary syndrome (PCOS) and endocrine disrupting chemicals (EDCs)

E Palioura, E Diamanti-Kandarakis - Reviews in Endocrine and Metabolic …, 2015 - Springer
Polycystic ovary syndrome (PCOS) is a heterogeneous disorder of unclear etiopathogenesis
that is likely to involve genetic and environmental components synergistically contributing to …

Metabolic profiles characterizing different phenotypes of polycystic ovary syndrome: plasma metabolomics analysis

Y Zhao, L Fu, R Li, LN Wang, Y Yang, NN Liu… - BMC medicine, 2012 - Springer
Background Polycystic ovary syndrome (PCOS) is a heterogeneous endocrine disorder
accompanied with an increased risk of developing type 2 diabetes mellitus and …

Resveratrol treatment in patients with polycystic ovary syndrome decreased pro‐inflammatory and endoplasmic reticulum stress markers

S Brenjian, A Moini, N Yamini, L Kashani… - American Journal of …, 2020 - Wiley Online Library
Problem Polycystic ovary syndrome (PCOS) is associated with endoplasmic reticulum (ER)
stress and pro‐inflammatory condition. The aim of the present study was to evaluate the …

[HTML][HTML] A landscape analysis of the potential role of polyphenols for the treatment of Polycystic Ovarian Syndrome (PCOS)

R Rani, YA Hajam, R Kumar, RA Bhat, S Rai… - Phytomedicine Plus, 2022 - Elsevier
Abstract Background Polycystic Ovarian Syndrome (PCOS) is an under-recognized, under-
diagnosed and under-studied disorder; its prevalence varies between 5–26%, 6–10% of …

Metabolomic insight into polycystic ovary syndrome—An overview

A Rajska, M Buszewska-Forajta, D Rachoń… - International journal of …, 2020 - mdpi.com
Searching for the mechanisms of the polycystic ovary syndrome (PCOS) pathophysiology
has become a crucial aspect of research performed in the last decades. However, the …

Up-regulated expression of WNT5a increases inflammation and oxidative stress via PI3K/AKT/NF-κB signaling in the granulosa cells of PCOS patients

Y Zhao, C Zhang, Y Huang, Y Yu, R Li… - The Journal of …, 2015 - academic.oup.com
Context: Polycystic ovary syndrome (PCOS) is a heterogeneous endocrine disorder
accompanied by chronic low-grade inflammation, but the molecular mechanism remains …